Author:
Bieńkowski Michał,Preusser Matthias
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical),Neurology
Reference109 articles.
1. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomized, controlled, open-label, phase 3 trial.;Weber;Lancet Oncol,2015
2. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous nonsmall-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.;Rizvi;Lancet Oncol,2015
3. PD-1 blockade with nivolumab in relapsed or refractory Hodgkins lymphoma.;Ansell;New Engl J Med,2015
4. Inflammation and cancer: back to Virchow L;Balkwill;ancet,2001
5. Cancer classification using the Immunoscore: a worldwide task force.;Galon;J Transl Med,2012
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献